Transdermal delivery systems may additionally cause local skin reactions , including redness, itching, or irritation at the application site
Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJ, Charytan DM, et al
Cignas 2026 commercial PA criteria for Wegovy require five elements: BMI of 30 or higher, or BMI 27 to 29.9 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, OSA, CVD), documentation of a structured weight management program for at least 6 months in the past 24 months, prescriber attestation that lifestyle changes alone have been inadequate, age 18 or older, and concurrent reduced-calorie diet and physical activity
Red stools can be alarming as they may indicate bleeding
10.1111/j.1432-1033.1987.tb11155.x Eur J Biochem
[3, 4] These findings support the concept of microdosing as a tolerable and effective approach for individuals sensitive to standard dosing regimens